Work

Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product Effectiveness

Year: 2021

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.2272

Authors: Nirosha Mahendraratnam, Kerra Mercon, Mira Gill, Laura Benzing, Mark B. McClellan

Institution: Duke University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Merck, Novartis, Teva Pharmaceutical Industries, AbbVie, Genentech

OpenAlex ID: W3156947925

FWCI: 7.749

Cites: 8

Cited by: 63

Related to: 10